GT Biopharma, Inc.

GTBP

$0.25

-10.57%

N/A-$0.03

Healthcare

Biotechnology

NASDAQ

Active Trading

GT Biopharma, Inc. is a biopharmaceutical company in the clinical development phase, dedicated to discovering and bringing to market novel immuno-oncology treatments. ...

C-Suite Executives

(0)

The C-suite executives form a cohesive leadership team driving the company's financial strategy and innovation.

Key Team Members

No executives available for this level

Founder / CEO

C-Level

Board

Director / Board

Other

Key Executives

Name	Title	Compensation	Gender	Year Born	Status
Michael Martin Breen	President, CEO & Executive Chairman	USD 1,385,647		1963	Active
Alan Louis Urban	Chief Financial Officer & Secretary	USD 626,310		1968	Active

Executive Compensation

(deduped by latest filing date per person-year)

Filing Date	Year	Name	Position	Level	Salary	Bonus	Stock Award	Option Award	Incentive	Other	Total
2026-07-02	2025	Michael Breen Chairman,	Chief Chief Executive Officer, and President President	Founder / CEO	$641.02K	$585.06K	$0	$342.00K	$0	$159.57K	$1.73M
2026-07-02	2025	Alan Urban	Chief Chief Financial Officer	C-Level	$393.75K	$157.50K	$0	$113.00K	$0	$75.06K	$739.31K
2026-07-02	2024	Michael Breen Chairman,	Chief Chief Executive Officer, and President President	Founder / CEO	$556.20K	$417.15K	$0	$0	$0	$213.62K	$1.19M
2026-07-02	2024	Alan Urban	Chief Chief Financial Officer	C-Level	$218.75K	$87.50K	$0	$40.68K	$0	$30.85K	$377.78K

Total Compensation Trend

Sum of disclosed compensation by year (USD million)

Key Roles Compensation Lines

Top founder/C-level executives over time (USD million)

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer